Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

MMP-3 (-1171 5A/6A; Lys45Glu) variants affect serum levels of matrix metalloproteinase (MMP)-3 and correlate with severity of COPD: A study of MMP-3, MMP-7 and MMP-12 in a Tunisian population.

Bchir S, Ben Nasr H, Garrouch A, Ben Anes A, Abbassi A, Tabka Z, Chahed K.

J Gene Med. 2018 Jan;20(1). doi: 10.1002/jgm.2999. Epub 2017 Dec 29.

PMID:
29165854
2.

Matrix Metalloproteinase-9 (279R/Q) Polymorphism is Associated with Clinical Severity and Airflow Limitation in Tunisian Patients with Chronic Obstructive Pulmonary Disease.

Bchir S, Nasr HB, Hakim IR, Anes AB, Yacoub S, Garrouch A, Benzarti M, Bauvois B, Tabka Z, Chahed K.

Mol Diagn Ther. 2015 Dec;19(6):375-87. doi: 10.1007/s40291-015-0163-2.

PMID:
26303146
4.

Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease.

Santus P, Casanova F, Biondi ML, Blasi F, Di Marco F, Centanni S.

Monaldi Arch Chest Dis. 2009 Mar;71(1):15-20.

PMID:
19522160
5.

[Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma].

Lu ZQ, Wang YM, Cao YY, Zhang QJ, Zhang XH, Li YH, Wang HS, Xie HL, Jiao BH, Zhang JH.

Ai Zheng. 2007 May;26(5):463-8. Chinese.

PMID:
17672933
6.

Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.

Abd-Allah SH, El-Shal AS, Shalaby SM, Pasha HF, Abou El-Saoud AM, Abdel Galil SM, Mahmoud TA.

IUBMB Life. 2015 Dec;67(12):934-42. doi: 10.1002/iub.1446. Epub 2015 Oct 28.

7.

Is MMP-7 gene polymorphism a possible risk factor for chronic obstructive pulmonary disease in Turkish patients.

Mogulkoc U, Coskunpinar E, Aynaci E, Cağlar E, Ortakoylu MG, Ozkan G, Oltulu YM, Eraltan IY.

Genet Test Mol Biomarkers. 2012 Jun;16(6):519-23. doi: 10.1089/gtmb.2011.0271. Epub 2012 Mar 14.

PMID:
22417142
8.

Relationship between plasma matrix metalloproteinase levels, pulmonary function, bronchodilator response, and emphysema severity.

Koo HK, Hong Y, Lim MN, Yim JJ, Kim WJ.

Int J Chron Obstruct Pulmon Dis. 2016 May 27;11:1129-37. doi: 10.2147/COPD.S103281. eCollection 2016.

9.

[Association of matrix metalloproteinase-3 serum level and the promoter 5A/6A polymorphism of the MMP-3 gene with atherosclerotic cerebral infarction].

Huang X, Zhu M, Jin X, Zhang D, Wang L, Ye Z.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2008 Dec;25(6):653-6. Chinese.

PMID:
19065524
10.

Matrix Metalloproteinase 3 Gene Polymorphism and Its Level Predict Morbidity After Acute Myocardial Infarction.

Abd El-Aziz TA, Mohamed RH.

Am J Clin Pathol. 2016 Jan;145(1):134-9. doi: 10.1093/ajcp/aqv008.

PMID:
26712881
11.

Association of Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Gene Variants with Ischemic Stroke and Its Subtype.

Huang XY, Han LY, Huang XD, Guan CH, Mao XL, Ye ZS.

J Stroke Cerebrovasc Dis. 2017 Feb;26(2):368-375. doi: 10.1016/j.jstrokecerebrovasdis.2016.09.034. Epub 2016 Oct 25.

PMID:
27793533
12.

MMP-9 genetic polymorphism may confer susceptibility to COPD.

Jiang S, Yang ZH, Chen YY, He Z, Zhou Y, Gao Y, Zhang Q, Tan MQ.

Genet Mol Res. 2016 Apr 25;15(2). doi: 10.4238/gmr.15026272.

13.

Impact of Matrix Metalloproteinase 9 on COPD Development in Polish Patients: Genetic Polymorphism, Protein Level, and Their Relationship with Lung Function.

Gilowska I, Kasper Ł, Bogacz K, Szczegielniak J, Szymasek T, Kasper M, Czerwinski M, Sładek K, Majorczyk E.

Biomed Res Int. 2018 Dec 10;2018:6417415. doi: 10.1155/2018/6417415. eCollection 2018.

14.

Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese.

Huang XY, Han LY, Huang XD, Guan CH, Mao XL, Ye ZS.

Int J Neurosci. 2016 Oct;126(10):936-41. doi: 10.3109/00207454.2015.1088013. Epub 2015 Sep 22.

PMID:
26314579
15.

Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.

Navratilova Z, Zatloukal J, Kriegova E, Kolek V, Petrek M.

Respirology. 2012 Aug;17(6):1006-12. doi: 10.1111/j.1440-1843.2012.02197.x.

PMID:
22591289
16.

[Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].

Fang SM, Jin X, Li Y, Wang R, Guo W, Wang N, Zhang JH.

Ai Zheng. 2005 Mar;24(3):305-10. Chinese.

PMID:
15757531
17.

Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.

Linder R, Rönmark E, Pourazar J, Behndig A, Blomberg A, Lindberg A.

Respir Res. 2015 Feb 21;16:28. doi: 10.1186/s12931-015-0188-4.

18.

Association of matrix metalloproteinase-3 gene 5A/6A polymorphism with the recurrence of ischemic stroke: A prospective observational study.

Huang X, Ye Q, Zhang Z, Huang X, Zhu Z, Chen Y, Li J, Chen S, Xia N, Mao X, Han L, Ye Z.

Brain Res. 2017 Nov 1;1674:55-61. doi: 10.1016/j.brainres.2017.08.009. Epub 2017 Aug 24.

PMID:
28843428
19.

Genotype-phenotype association of matrix metalloproteinase-3 polymorphism and its synergistic effect with smoking on the occurrence of acute coronary syndrome.

Liu PY, Li YH, Chan SH, Lin LJ, Wu HL, Shi GY, Chen JH.

Am J Cardiol. 2006 Oct 15;98(8):1012-7. Epub 2006 Aug 22.

PMID:
17027562
20.

MMP-1 and -3 promoter variants are indicative of a common susceptibility for skin and lung aging: results from a cohort of elderly women (SALIA).

Vierkötter A, Schikowski T, Sugiri D, Matsui MS, Krämer U, Krutmann J.

J Invest Dermatol. 2015 May;135(5):1268-1274. doi: 10.1038/jid.2015.7. Epub 2015 Jan 19.

Supplemental Content

Support Center